Compare iShares MSCI Germany (DAX) (EWG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs Zimmer Biomet Holdings Inc — how do they compare? iShares MSCI Germany (DAX) trades at $41.2, while Zimmer Biomet Holdings Inc trades at $92.9 (market cap $17.44B). The key difference: Zimmer Biomet Holdings Inc pays a 1.07% dividend while iShares MSCI Germany (DAX) pays none. Which is the better fit depends on your goals.
| EWG | ZBH | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $44.56 | $107.71 |
52-Week Low | $38.08 | $79.58 |
Market Cap | — | $17.44B |
Enterprise Value | — | $24.49B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG trades at $41.10, down 0.7% on the day, with a neutral technical signal and bearish moving averages. Key support is at $41 and resistance at $42. The stock lacks available financial ratios, and a dividend of $0.83 is scheduled for June 2026. Recent news highlights German economic policies and ECB rate decisions influencing European market sentiment.
The outlook is cautious due to limited fundamental data and mixed technical indicators. Risks include macroeconomic volatility from energy prices and ECB policy shifts. Analyst sentiment is neutral, with no clear consensus on price targets or ratings available.
Zimmer Biomet (ZBH) trades at $92.94, up 2.1% on the day, with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with a 70% gross margin and positive cash flow trends, though net income margin has declined from 13.8% in 2023 to 8.6% in 2025. Recent developments include expansion in Asia Pacific and a planned $1 billion share repurchase, indicating management confidence.
ZBH presents a moderate growth opportunity with a consensus price target of $97.67, offering ~5% upside. Risks include rising debt levels and competitive pressures in medical devices. Analyst sentiment is mixed with 40% buy ratings, but institutional activity and strategic acquisitions support a stable outlook for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
